Acumen Common Stock Total Equity vs Cash Analysis
| ABOS Stock | USD 2.70 0.05 1.89% |
Acumen Pharmaceuticals financial indicator trend analysis is way more than just evaluating Acumen Pharmaceuticals prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Acumen Pharmaceuticals is a good investment. Please check the relationship between Acumen Pharmaceuticals Common Stock Total Equity and its Cash accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Acumen Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. For more information on how to buy Acumen Stock please use our How to Invest in Acumen Pharmaceuticals guide.
Common Stock Total Equity vs Cash
Common Stock Total Equity vs Cash Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Acumen Pharmaceuticals Common Stock Total Equity account and Cash. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between Acumen Pharmaceuticals' Common Stock Total Equity and Cash is -0.36. Overlapping area represents the amount of variation of Common Stock Total Equity that can explain the historical movement of Cash in the same time period over historical financial statements of Acumen Pharmaceuticals, assuming nothing else is changed. The correlation between historical values of Acumen Pharmaceuticals' Common Stock Total Equity and Cash is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Common Stock Total Equity of Acumen Pharmaceuticals are associated (or correlated) with its Cash. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cash has no effect on the direction of Common Stock Total Equity i.e., Acumen Pharmaceuticals' Common Stock Total Equity and Cash go up and down completely randomly.
Correlation Coefficient | -0.36 |
| Relationship Direction | Negative |
| Relationship Strength | Insignificant |
Common Stock Total Equity
The total value of common stock equity held by shareholders, representing their ownership interest in the company.Cash
Cash refers to the most liquid asset of Acumen Pharmaceuticals, which is listed under current asset account on Acumen Pharmaceuticals balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from Acumen Pharmaceuticals customers. The amounts must be unrestricted with restricted cash listed in a different Acumen Pharmaceuticals account. The total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts.Most indicators from Acumen Pharmaceuticals' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Acumen Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Acumen Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. For more information on how to buy Acumen Stock please use our How to Invest in Acumen Pharmaceuticals guide.Selling General Administrative is likely to gain to about 19.8 M in 2024, whereas Issuance Of Capital Stock is likely to drop slightly above 83.5 M in 2024.
| 2021 | 2022 | 2023 | 2024 (projected) | Interest Income | 84K | 2.4M | 8.2M | 8.6M | Net Interest Income | 84K | 2.4M | 8.2M | 8.6M |
Acumen Pharmaceuticals fundamental ratios Correlations
Click cells to compare fundamentals
Acumen Pharmaceuticals Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Pair Trading with Acumen Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Acumen Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acumen Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Moving together with Acumen Stock
Moving against Acumen Stock
| 0.68 | JPHLF | Japan Post Holdings | PairCorr |
| 0.49 | JPSTF | JAPAN POST BANK | PairCorr |
| 0.48 | HPQ | HP Inc Fiscal Year End 19th of November 2024 | PairCorr |
| 0.44 | MRK | Merck Company Financial Report 6th of August 2024 | PairCorr |
| 0.4 | MZHOF | Mizuho Financial Earnings Call Next Week | PairCorr |
The ability to find closely correlated positions to Acumen Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Acumen Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Acumen Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Acumen Pharmaceuticals to buy it.
The correlation of Acumen Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Acumen Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Acumen Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Acumen Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Acumen Stock Analysis
When running Acumen Pharmaceuticals' price analysis, check to measure Acumen Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Acumen Pharmaceuticals is operating at the current time. Most of Acumen Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Acumen Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Acumen Pharmaceuticals' price. Additionally, you may evaluate how the addition of Acumen Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.